First participant receives Evategrel in CureGene’s trial

​CureGene Pharmaceutical has dosed the first participant in its pivotal clinical trial of Evategrel, a next-generation antiplatelet therapy, in the US.

The post First participant receives Evategrel in CureGene’s trial appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism
Japan approves Sanofi’s Sarclisa combo for MM treatment
Charles River collaborates with Lilly TuneLab platform
MAIA activates new site for THIO-101 Phase II trial
Biogen to acquire RayThera for up to $1bn

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us